Department of Neurology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
J Zhejiang Univ Sci B. 2010 Jul;11(7):531-8. doi: 10.1631/jzus.B0900380.
The 39-item Parkinson's Disease Questionnaire (PDQ-39) has been tested in many languages, but not in Chinese mainland. We aimed to assess the Chinese (mainland) version of the PDQ-39. Seventy-one subjects with Parkinson's disease (PD) completed the PDQ-39 and the Medical Outcomes Study 36-item Short Form Health Survey (SF-36). All subjects were retested with the PDQ-39 a week later. The united Parkinson's disease rating scale (UPDRS) and the Hoehn and Yahr (H & Y) scale were also used to evaluate the subjects. Reliability was assessed by Cronbach's alpha and intra-class correlation coefficient (ICC). Validity was examined in terms of agreement with SF-36, UPDRS, and H & Y scales. The Chinese (mainland) version of the PDQ-39 demonstrated acceptable reliability (Cronbach's alpha: 0.84-0.88; ICC: 0.56-0.82). The item-total correlations (0.33-0.88) and scaling success rates (77.56%) indicated satisfactory convergent and discriminant validity of the PDQ-39 items. The correlations between related constructs of the PDQ-39 and UPDRS (r=0.44-0.68) and between those of the PDQ-39 and SF-36 (r=(-0.46)-(-0.69)) were all statistically significant (P<0.01). Except for stigma, cognitions, and bodily discomfort, all other dimensions of the PDQ-39 significantly discriminated patients at different H & Y stages indicated by the H & Y scale. Although our observations indicate that some problematic subscales of this version of the PDQ-39 could be improved upon, this study suggests acceptable reliability and validity of the Chinese (mainland) version of the PDQ-39.
帕金森病问卷(PDQ-39)已在许多语言中进行了测试,但尚未在中国大陆进行。我们旨在评估 PDQ-39 的中文(大陆)版本。71 名帕金森病(PD)患者完成了 PDQ-39 和医疗结局研究 36 项简短健康调查(SF-36)。所有患者一周后用 PDQ-39 进行了复测。还使用统一帕金森病评定量表(UPDRS)和 Hoehn 和 Yahr(H & Y)量表来评估患者。通过 Cronbach's alpha 和组内相关系数(ICC)评估可靠性。通过与 SF-36、UPDRS 和 H & Y 量表的一致性来检查有效性。PDQ-39 的中文(大陆)版本具有可接受的可靠性(Cronbach's alpha:0.84-0.88;ICC:0.56-0.82)。项目总分相关性(0.33-0.88)和评分成功率(77.56%)表明 PDQ-39 项目具有令人满意的收敛和判别有效性。PDQ-39 与 UPDRS 相关结构之间的相关性(r=0.44-0.68)以及 PDQ-39 与 SF-36 之间的相关性(r=(-0.46)-(-0.69))均具有统计学意义(P<0.01)。除耻辱感、认知和身体不适外,PDQ-39 的所有其他维度都能显著区分 H & Y 量表所示的不同 H & Y 阶段的患者。尽管我们的观察表明,该版本 PDQ-39 的一些有问题的子量表可以改进,但本研究表明 PDQ-39 的中文(大陆)版本具有可接受的可靠性和有效性。